Clinical Trial Update: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase I trial evaluating stereotactic body radiotherapy for metastatic or recurrent platinum-resistant ovarian cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Epithelial Cancer
• Ovarian Germ Cell Tumor
• Peritoneal Cancer

Snippet

Sponsor: Stanford University | Conditions: Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor | Phase 1 | Status: TERMINATED